Paper40136715
Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma.
Zhra M and 4 others. Cells, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma. Papers, record 40136715. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40136715
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Sirtuins | Major topic |
| Liver Neoplasms | Major topic |
| Metabolic Diseases | Major topic |
| Humans | |
| Animals | |
| Non-alcoholic Fatty Liver Disease | |
| Dysbiosis |
Source PubMed
References275
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20078219 | Nonalcoholic fatty liver disease: pathology and pathogenesis. | Annu Rev Pathol | 2010 | https://conductscience.org/library/papers/20078219 | PubMed |
| 2 | 35782983 | Hepatic SIRT6 deficit promotes liver tumorigenesis in the mice models. | Genes Dis | 2022 | https://conductscience.org/library/papers/35782983 | PubMed |
| 3 | 22297845 | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. | Nature | 2012 | https://conductscience.org/library/papers/22297845 | PubMed |
| 4 | 30525304 | SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. | Mol Nutr Food Res | 2019 | https://conductscience.org/library/papers/30525304 | PubMed |
| 5 | 28983565 | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28983565 | PubMed |
| 6 | 28338198 | The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28338198 | PubMed |
| 7 | 20450879 | Regulation of SIRT1 in cellular functions: role of polyphenols. | Arch Biochem Biophys | 2010 | https://conductscience.org/library/papers/20450879 | PubMed |
| 8 | 24297700 | The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. | FASEB J | 2014 | https://conductscience.org/library/papers/24297700 | PubMed |
| 9 | 25522783 | Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25522783 | PubMed |
| 10 | 36057627 | Sirtuin 6 maintains epithelial STAT6 activity to support intestinal tuft cell development and type 2 immunity. | Nat Commun | 2022 | https://conductscience.org/library/papers/36057627 | PubMed |
| 11 | 28166203 | LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. | Oncogene | 2017 | https://conductscience.org/library/papers/28166203 | PubMed |
| 12 | 36980194 | Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection. | Cells | 2023 | https://conductscience.org/library/papers/36980194 | PubMed |
| 13 | 24874077 | Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24874077 | PubMed |
| 14 | 33806509 | Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33806509 | PubMed |
| 15 | 27270872 | Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. | Phytother Res | 2016 | https://conductscience.org/library/papers/27270872 | PubMed |
| 16 | 31024205 | Hepatocellular Carcinoma: Etiology and Current and Future Drugs. | J Clin Exp Hepatol | 2019 | https://conductscience.org/library/papers/31024205 | PubMed |
| 17 | 34055983 | Biodiversity of Gut Microbiota: Impact of Various Host and Environmental Factors. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/34055983 | PubMed |
| 18 | 36101744 | Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction. | Genet Res (Camb) | 2022 | https://conductscience.org/library/papers/36101744 | PubMed |
| 19 | 20685656 | SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20685656 | PubMed |
| 20 | 28352996 | Mechanisms and consequences of intestinal dysbiosis. | Cell Mol Life Sci | 2017 | https://conductscience.org/library/papers/28352996 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42652254 | Dietary Regulation of Intestinal Stem Cell Function: Nutrient-Sensing, Microbiota-Mediated, and Regenerative Mechanisms from a Dietetic Perspective. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652254 | PubMed |
| 42516979 | SIRT3 deficiency aggravates renal injury and fibrosis in chronic kidney disease and is associated with intestinal barrier dysfunction and gut microbiota dysbiosis. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42516979 | PubMed |
| 42317765 | Progress on the correlation between sepsis and gut microbiota: a narrative review. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42317765 | PubMed |
| 42188320 | Algae-Derived Bioactives Reprogram the Gut-SIRT1-Kisspeptin Axis in Polycystic Ovary Syndrome. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42188320 | PubMed |
| 41751214 | Mechanistic Links Between the Gut Microbiome and Longevity Therapeutics. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751214 | PubMed |
| 41750556 | Gut Microbial Composition, Oxidative Stress, and Immunity in Metabolic Disease: Toward Personalized Interventions. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41750556 | PubMed |
| 41262444 | Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41262444 | PubMed |
| 41065901 | How microbiota influence maternal blood disorder in miscarriage. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/41065901 | PubMed |
| 41063289 | Gut microbiome-based machine learning model for early colorectal cancer and adenoma screening. | Gut Pathog | 2025 | https://conductscience.org/library/papers/41063289 | PubMed |
| 40497987 | Microbial Metabolite Effects on Vasculogenic Mimicry in Metastatic Cancers. | Cells | 2025 | https://conductscience.org/library/papers/40497987 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40136715
GET https://conductscience.org/api/papers/v1/40136715/references?page=2